Long-term Follow-up Study for Patients Treated With CLBR001 CAR-T

Clinical trial NCT04488354 · COMPLETED

Trial details

NCT number: NCT04488354
Sponsor: Calibr, a division of Scripps Research
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Relapsed/Refractory B-cell Lymphomas Diffuse Large B-Cell Lymphoma (DLBCL)Follicular Lymphoma (FL)Chronic Lymphocytic Leukemia (CLL)Marginal Zone Lymphoma (MZL)Mantle Cell Lymphoma (MCL)Small Lymphocytic Lymphoma (SLL)Primary Mediastinal Large B Cell Lymphoma Transformed Follicular Lymphoma Waldenstrom Macroglobulinemia Lymphoplasmacytic Lymphoma Burkitt Lymphoma

Start date: 2021-01-21
Primary completion: 2025-10-06
Enrollment: 16

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.